Planet 13 is betting that the Sunshine State will finally climb on the adult-use legalization bandwagon.
Shares of Novavax (NASDAQ: NVAX) were soaring 24.1% higher as of 12:35 p.m. ET on Tuesday. European Medicines Agency head Emma Cooke told European Union health ministers on Tuesday that Novavax's COVID-19 vaccine could be authorized in the "near future." Also, a study led by the University of Oxford found that a second dose of Novavax's vaccine following an initial dose of AstraZeneca's (NASDAQ: AZN) vaccine was significantly more effective than two doses of the AstraZeneca vaccine.
These companies produce the only thing that matters.
On a day when Wall Street is getting a relief rally as investors reassess a possibly less severe Omicron variant, pet insurance outfit Trupanion (NASDAQ: TRUP) is up a whopping 39% as of 2:10 p.m. ET. The big news is that pet e-commerce leader Chewy (NYSE: CHWY) is making its foray into pet insurance, and has decided to partner with Trupanion to do so. Chewy will offer its some 20 million customers access to wellness and insurance plans for accidents, illnesses, and chronic conditions for dogs and cats.
Wood has made crazier calls before, and she's been right on the money.
Apple did not immediately respond to a Reuters request for comment. The five-year agreement was made when Cook made visits to China in 2016 to quash a host of regulatory action against the company, the report said, citing interviews and internal Apple documents. Cook lobbied Chinese officials, who believed the company was not contributing enough to the local economy, and signed the agreement with a Chinese government agency, making concessions to Beijing and winning key legal exemptions, the report added.
The Dow Jones rallied as Apple stock hit a record high. Tesla stock popped after CEO Elon Musk lashed out. The Donald Trump SPAC surged.
GameStop is expected to report a fiscal third-quarter adjusted net loss of 52 cents a share with sales of $1.19 billion, according to FactSet.
Jack in the Box CEO Darin Harris joins Yahoo Finance Live to discuss the fast-food chain's acquisition of Del Taco and its handling of rising inflation costs on its menu.
Companies such as DigitalOcean Holdings (NYSE: DOCN) and Palantir (NYSE: PLTR) fit this description. On the surface, DigitalOcean might seem like a disadvantaged enterprise. DigitalOcean offers easy-to-understand plans with straightforward pricing, making evaluating the service more accessible for entrepreneurs.
Hundreds of Chinese companies are listed on U.S. markets. But which are the best Chinese stocks to buy or watch right now? JD.com , Nio, Li Auto, Xpeng and BYD Co.. China is the world's most-populous nation and the second-largest economy with a booming urban middle class and amazing entrepreneurial activity.
In this article, we discuss the 10 best hydrogen fuel stocks to buy today. If you want to skip our detailed analysis of these stocks, go directly to the 5 Hydrogen Fuel Cell Stocks to Buy Today. Hydrogen fuel is an attractive source for power generation, transportation, domestic, and industrial applications, since it is a […]
Shares of Comcast (NASDAQ: CMCSA) turned "red" on a "green" day for the stock market -- and Comcast has only itself to blame for it. As of 1:11 p.m. ET, Comcast stock is down an even 5%. In a business update revealed at UBS' investor conference today, Comcast CEO Brian Roberts advised that the company will be looking at just 7% to 8% growth in earnings before interest, taxes, depreciation, and amortization (EBITDA) when it reports earnings next month, according to StreetInsider.com.
Hydrogen fuel-cell stocks kicked off Tuesday on a strong note, with shares of Plug Power (NASDAQ: PLUG), Bloom Energy (NYSE: BE), and Nikola (NASDAQ: NKLA) jumping 7.7%, 7%, and 5.7%, respectively, as of 2:25 p.m. ET. Multiple developments that confirm rising global interest in green hydrogen and fuel-cell technology reignited investor interest in leading hydrogen stocks today. Meanwhile, the United Arab Emirates (UAE) is collaborating with French utility Engie to invest $5 billion to develop renewable energy and hydrogen projects with two gigawatts of capacity by 2030.
Buffett prefers assets with clear, material use, and these definitely fit the bill.
In this article we are going to use hedge fund sentiment as a tool and determine whether Moderna, Inc. (NASDAQ:MRNA) is a good investment right now. We like to analyze hedge fund sentiment before conducting days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy League graduates, expert […]
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
(Bloomberg) -- Jeffrey Gundlach sees “rough waters” ahead for financial markets as the Federal Reserve is poised to accelerate the end of quantitative easing and then turn toward raising interest rates. Most Read from BloombergThe World’s Relentless Demand for Chips Turns Deadly in MalaysiaSand and Soldiers Mix as Troops Move In to Protect Cancun TouristsEven in the Metaverse, Not All Identities Are Created EqualThe $300 Billion Plan to Bring Green Power to China’s MegacitiesMeet the New Climate
Shares of Moderna (NASDAQ: MRNA) were rising 3.1% as of 12:51 p.m. ET. The gain came after results were announced for a COVID-19 vaccine study led by the University of Oxford. This study found that a second dose of Moderna's vaccine following a first dose of either the Pfizer-BioNTech vaccine or the AstraZeneca vaccine was more effective than two doses of the two other vaccines.
Vaccine stocks were muted Tuesday after test results indicated omicron might elude some of the protection provided by Pfizer's Covid shot.
The Chinese tech giant has lost almost a quarter of its market value in the past month amid regulatory pressures and signs of slowing growth.